Refine by
Clinically Validate Equipment & Supplies
37 equipment items found
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Designed to deliver critical information to guide chemotherapy decision-making, Immunoscore® can be used in Stage II localized colon cancer to help physicians identify patients who may be spared adjuvant chemotherapy, and in Stage III localized colon cancer to inform them about the optimal treatment duration for their patients. ...
by:Starling Sugical based inDublin 2, IRELAND
The QuickStitch is a single-use disposable device. It comes preloaded with 34 tags (knotless sutures). It enables wound closure with clinical results superior to sutures and staplers at similar speed to a skin ...
Manufactured by:Nanovis based inColumbia City, INDIANA (USA)
nanoVIS Ti Surface Technology, applicable to CP Ti and Ti alloy, is a bioceramic bonegrowth nanotube surface specifically designed to increase and accelerate biologic ...
Manufactured by:Exosome Diagnostics, Inc. based inWaltham, MASSACHUSETTS (USA)
The only exosome-based test that provides unique, actionable intelligence to help you decide if biopsy is necessary; independent of PSA and other standard of care (SOC) features. Connect with a representative in your area for more information today. ...
by:Vaxxas, Inc. based inCambridge, MASSACHUSETTS (USA)
Vaxxas is commercializing a novel vaccination technology that dramatically enhances the performance of existing and next-generation vaccines. The core of Vaxxas technology platform is a High Density Microarray Patch (HD-MAP). Vaxxas' HD-MAP is readily fabricated by injection molding to produce small patches each with thousands of very short (~0.25mm) microprojections. Vaxxas has developed novel ...
Manufactured by:OncoQR ML GmbH based inVienna, AUSTRIA
OQR400: to a 4th blockbuster-clinically validated target (not ...
by:Click Therapeutics, Inc based inNew York, NEW YORK (USA)
Clickheart is under development as a clinically-validated digital program for acute coronary ...
by:Click Therapeutics, Inc based inNew York, NEW YORK (USA)
CT-161 is under development as a clinically-validated digital program for overactive ...
Manufactured by:Omron Healthcare, Inc based inHoofddorp, NETHERLANDS
OMRON VIVA is a medical device with clinically validated accuracy of key parameters that allow you to better understand your heart's health (visceral fat, fat and skeletal muscle) and are proven to be predictive for cardiovascular ...
Manufactured by:Rudolf Riester GmbH based inJungingen, GERMANY
ri-champion N – the easy-to-use, clinically validated device according to BHS-standard A/A. It features irregular heartbeat recognition, memory storage up to 99 readings, pulse tone anddate and time. ...
by:Qardio, Inc. based inSan Francisco, CALIFORNIA (USA)
Track and manage COVID-19 symptoms over time. QardioSpO2 is a clinically validated pulse oximeter that measures the blood oxygen saturation levels (SpO2) and pulse rate of the body via the fingertip sensor. Compatible with iOS and Android devices. ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Immunoscore® for Rectal Cancer can help identify patients with LARC who are at a low risk of relapse and may be good candidates for organ preservation. Immunoscore® is available through an Innovation Access Program while the company conducts clinical validation ...
Manufactured by:Breathomix based inLeiden, NETHERLANDS
The SpiroNose is a technical and clinical validated integration between routine spirometry and electronic nose (eNose) technology connected in series with each other. Therefore, technique allows diagnosis and stratification of patients with cancer, infectious and inflammatory disease in the doctor’s office. ...
Manufactured by:PsiOxus Therapeutics Ltd. based inAbingdon, UNITED KINGDOM
Our clinically validated T-SIGn® viral vector platform delivers multiple transgene payloads that re-program the tumor microenvironment of both primary and metastatic tumors. Our platform can integrate rationally designed synthetic agents to unleash the power of the immune system, including genetically engineered cell ...
by:Castle Biosciences, Inc. based inFriendswood, TEXAS (USA)
Predicting Individual Risk of Metastasis: DecisionDx-SCC is now commercially available. DecisionDx-SCC is clinically validated as a significant predictor of metastasis and the strongest predictor of risk compared to traditional clinical and pathological factors. DecisionDx-SCC complements traditional prognostic risk assessment factors, enabling ...
Manufactured by:ForaCare Suisse AG based inSt. Gallen, SWITZERLAND
Mobility Has Never Been Easier, With the most compact design and rechargeable battery, the FORA Diamond MINI accompanies you on your travels wherever life takes you. Featuring clinically validated accuracy for your confidence, and Bluetooth Connectivity to iFORA App that empowers smart diabetes management anywhere anytime. ...
by:Vigilant Biosciences, Inc. based inAustin, TEXAS (USA)
Vigilant Biosciences® product is based on advanced patented technology, including an innovative methodology for assessing multiple biomarkers that, together with other clinical factors, can aid clinicians in the early detection of oral cancer. The clinically validated† test contributes to early and accurate† detection of oral ...
Manufactured by:Endodiag based inParis, FRANCE
Endodiag together with several expert gynecologists has developed EndoGram, a 10-biomarker test based on the analysis of biopsies taken during surgery. Thanks to a proprietary algorithm combining other patient clinical factors, EndoGram provides for each patient a risk of disease recurrence score and a biological profile aimed to help the physician discard unsuitable treatments. ...
Manufactured by:ForaCare Suisse AG based inSt. Gallen, SWITZERLAND
The FORA® 6 Connect lets users share vital health information to family and loved ones, keeping everyone connected through the iFORA healthcare App. With the ability to measure multiple-parameters in a single device, clinically validated accuracy for your confidence, and with Bluetooth connectivity, achieve more than just comprehensive diabetes ...
Manufactured by:Boston Pharmaceuticals based inCambridge, MASSACHUSETTS (USA)
BOS-475 is a selective BET (bromodomain and extra terminal) inhibitor. BOS-475 potently inhibits multiple clinically validated pathways (IL-12/IL-23-p40, Th17 cytokines and TNF) relevant to psoriasis pathophysiology. BOS-475 demonstrates broad inhibitory activities on other key disease-relevant immune-inflammatory mediators such as MCP-1, IL-6, and CXCL10 & ...